Skip to main content
Erschienen in: Journal of Neural Transmission 12/2009

01.12.2009 | Basic Neurosciences, Genetics and Immunology - Original Article

Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin–proteasome system in PC12D cells

verfasst von: Ichiro Kawahata, Hirofumi Tokuoka, Hasan Parvez, Hiroshi Ichinose

Erschienen in: Journal of Neural Transmission | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Abstract

Tyrosine hydroxylase (TH) is a rate-limiting enzyme for the biosynthesis of catecholamines including dopamine. The relationship between proteasomal dysfunction and the etiology of Parkinson’s disease has been suggested, but it is unknown if TH protein is affected by proteasomal dysfunctions. Here, we examined the effect of inhibition of ubiquitin–proteasomal pathway on biochemical characteristics of TH protein in the neuronal cells. Inhibition of 20S or 26S proteasome by proteasome inhibitor I, or MG-132 in NGF-differentiated PC12D cells induced dot-like immunoreactivities with the anti-40Ser-phosphorylated TH (p40-TH) antibody. These dots were tightly co-localized with ubiquitin and positive to Thioflavine-S staining. These dot-like immunoreactivities were not obvious when immunostaining was performed against total-TH or choline acetyltransferase. Western blotting analysis showed time-dependent increase of p40-TH in the Triton-insoluble fractions. We also examined the effect of okadaic acid, an inhibitor of protein phosphatase 2A, which is a phosphatase acting on p40-TH. Okadaic acid increased the amount of insoluble p40-TH. These data suggest that p40-TH is prone to be insolubilized and aggregated by dysfunction of an ubiquitin–proteasome system in PC12D cells.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Carrard G, Bulteau AL, Petropoulos I, Friguet B (2002) Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol 34:1461–1474CrossRefPubMed Carrard G, Bulteau AL, Petropoulos I, Friguet B (2002) Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol 34:1461–1474CrossRefPubMed
Zurück zum Zitat Daubner SC, Lauriano C, Haycock JW, Fitzpatrick PF (1992) Site-directed mutagenesis of serine 40 of rat tyrosine hydroxylase. J Biol Chem 267:12639–12646PubMed Daubner SC, Lauriano C, Haycock JW, Fitzpatrick PF (1992) Site-directed mutagenesis of serine 40 of rat tyrosine hydroxylase. J Biol Chem 267:12639–12646PubMed
Zurück zum Zitat Døskeland AP, Flatmark T (2002) Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form. Eur J Biochem 269:1561–1569CrossRefPubMed Døskeland AP, Flatmark T (2002) Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form. Eur J Biochem 269:1561–1569CrossRefPubMed
Zurück zum Zitat Dunkley PR, Bobrovskaya L, Graham ME, Nagy-Felsobuki EI, Dickson PW (2004) Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem 91:1025–1043CrossRefPubMed Dunkley PR, Bobrovskaya L, Graham ME, Nagy-Felsobuki EI, Dickson PW (2004) Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem 91:1025–1043CrossRefPubMed
Zurück zum Zitat Fujisawa H, Okuno S (2005) Regulatory mechanism of tyrosine hydroxylase activity. Biochem Biophys Res Commun 338:271–276CrossRefPubMed Fujisawa H, Okuno S (2005) Regulatory mechanism of tyrosine hydroxylase activity. Biochem Biophys Res Commun 338:271–276CrossRefPubMed
Zurück zum Zitat Haavik J, Schelling DL, Campbell DG, Andersson KK, Flatmark T, Cohen P (1989) Identification of protein phosphatase 2A as the major tyrosine hydroxylase phosphatase in adrenal medulla and corpus striatum: evidence from the effects of okadaic acid. FEBS Lett 251:36–42CrossRefPubMed Haavik J, Schelling DL, Campbell DG, Andersson KK, Flatmark T, Cohen P (1989) Identification of protein phosphatase 2A as the major tyrosine hydroxylase phosphatase in adrenal medulla and corpus striatum: evidence from the effects of okadaic acid. FEBS Lett 251:36–42CrossRefPubMed
Zurück zum Zitat Haycock JW (1990) Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J Biol Chem 265:11682–11691PubMed Haycock JW (1990) Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J Biol Chem 265:11682–11691PubMed
Zurück zum Zitat Haycock JW, Haycock DA (1991) Tyrosine hydroxylase in rat brain dopaminergic nerve terminals. J Biol Chem 266:5650–5657PubMed Haycock JW, Haycock DA (1991) Tyrosine hydroxylase in rat brain dopaminergic nerve terminals. J Biol Chem 266:5650–5657PubMed
Zurück zum Zitat Katoh-Semba R, Kitajima S, Yamazaki Y, Sano M (1987) Neuritic growth from a new subline of PC12 pheochromocytoma cells: cyclic AMP mimics the action of nerve growth factor. J Neurosci Res 17:36–44CrossRefPubMed Katoh-Semba R, Kitajima S, Yamazaki Y, Sano M (1987) Neuritic growth from a new subline of PC12 pheochromocytoma cells: cyclic AMP mimics the action of nerve growth factor. J Neurosci Res 17:36–44CrossRefPubMed
Zurück zum Zitat Kawahata I, Yagishita S, Hasegawa K, Natatsu I, Nagatsu T, Ichinose H (2009) Immunohistochemical analyses of human brain-stem type Lewy bodies and the localization of phosphorylated tyrosine hydroxylase in the midbrain. Biogenic Amines (in press) Kawahata I, Yagishita S, Hasegawa K, Natatsu I, Nagatsu T, Ichinose H (2009) Immunohistochemical analyses of human brain-stem type Lewy bodies and the localization of phosphorylated tyrosine hydroxylase in the midbrain. Biogenic Amines (in press)
Zurück zum Zitat Kuljis RO, Martín-Vasallo P, Peress NS (1989) Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex. Neurosci Lett 20:49–54CrossRef Kuljis RO, Martín-Vasallo P, Peress NS (1989) Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex. Neurosci Lett 20:49–54CrossRef
Zurück zum Zitat Le Bourdellès B, Horellou P, Le Caer JP, Denèfle P, Latta M, Haavik J, Guibert B, Mayaux JF, Mallet J (1991) Phosphorylation of human recombinant tyrosine hydroxylase isoforms 1 and 2: an additional phosphorylated residue in isoform 2, generated through alternative splicing. J Biol Chem 266:17124–17130PubMed Le Bourdellès B, Horellou P, Le Caer JP, Denèfle P, Latta M, Haavik J, Guibert B, Mayaux JF, Mallet J (1991) Phosphorylation of human recombinant tyrosine hydroxylase isoforms 1 and 2: an additional phosphorylated residue in isoform 2, generated through alternative splicing. J Biol Chem 266:17124–17130PubMed
Zurück zum Zitat Leal RB, Sim AT, Gonçalves CA, Dunkley PR (2002) Tyrosine hydroxylase dephosphorylation by protein phosphatase 2A in bovine adrenal chromaffin cells. Neurochem Res 27:207–213CrossRefPubMed Leal RB, Sim AT, Gonçalves CA, Dunkley PR (2002) Tyrosine hydroxylase dephosphorylation by protein phosphatase 2A in bovine adrenal chromaffin cells. Neurochem Res 27:207–213CrossRefPubMed
Zurück zum Zitat Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804–2815PubMed Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804–2815PubMed
Zurück zum Zitat McNaught KS, Olanow CW (2003) Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson’s disease. Ann Neurol 53(Suppl. 3):73–86CrossRef McNaught KS, Olanow CW (2003) Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson’s disease. Ann Neurol 53(Suppl. 3):73–86CrossRef
Zurück zum Zitat McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P (2001) Failure of the ubiquitin–proteasome system in Parkinson’s disease. Nat Rev Neurosci 2:589–594CrossRefPubMed McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P (2001) Failure of the ubiquitin–proteasome system in Parkinson’s disease. Nat Rev Neurosci 2:589–594CrossRefPubMed
Zurück zum Zitat Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase the initial step in norepinephrine biosynthesis. J Biol Chem 239:2910–2917PubMed Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase the initial step in norepinephrine biosynthesis. J Biol Chem 239:2910–2917PubMed
Zurück zum Zitat Nakashima S, Ikuta F (1984) Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains. J Neurol Sci 66:91–96CrossRefPubMed Nakashima S, Ikuta F (1984) Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains. J Neurol Sci 66:91–96CrossRefPubMed
Zurück zum Zitat Nakashima A, Hayashi N, Kaneko YS, Mori K, Egusa H, Nagatsu T, Ota A (2005) Deletion of N-terminus of human tyrosine hydroxylase type 1 enhances stability of the enzyme in AtT-20 cells. J Neurosci Res 81:110–120CrossRefPubMed Nakashima A, Hayashi N, Kaneko YS, Mori K, Egusa H, Nagatsu T, Ota A (2005) Deletion of N-terminus of human tyrosine hydroxylase type 1 enhances stability of the enzyme in AtT-20 cells. J Neurosci Res 81:110–120CrossRefPubMed
Zurück zum Zitat Okuno S, Fujisawa H (1985) A new mechanism for regulation of tyrosine 3-monooxygenase by end product and cyclic AMP dependent protein kinase. J Biol Chem 260:2633–2635PubMed Okuno S, Fujisawa H (1985) A new mechanism for regulation of tyrosine 3-monooxygenase by end product and cyclic AMP dependent protein kinase. J Biol Chem 260:2633–2635PubMed
Zurück zum Zitat Royo M, Fitzpatrick PF, Daubner SC (2005) Mutation of regulatory serines of rat tyrosine hydroxylase to glutamate: effects on enzyme stability and activity. Arch Biochem Biophys 434:266–274CrossRefPubMed Royo M, Fitzpatrick PF, Daubner SC (2005) Mutation of regulatory serines of rat tyrosine hydroxylase to glutamate: effects on enzyme stability and activity. Arch Biochem Biophys 434:266–274CrossRefPubMed
Zurück zum Zitat Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388:839–840CrossRefPubMed Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388:839–840CrossRefPubMed
Zurück zum Zitat Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469–6473CrossRefPubMed Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469–6473CrossRefPubMed
Zurück zum Zitat Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90:11282–11286CrossRefPubMed Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90:11282–11286CrossRefPubMed
Zurück zum Zitat Urano F, Hayashi N, Arisaka F, Kurita H, Murata S, Ichinose H (2006) Molecular mechanism for pterin-mediated inactivation of tyrosine hydroxylase: formation of insoluble aggregates of tyrosine hydroxylase. J Biochem 139:625–635CrossRefPubMed Urano F, Hayashi N, Arisaka F, Kurita H, Murata S, Ichinose H (2006) Molecular mechanism for pterin-mediated inactivation of tyrosine hydroxylase: formation of insoluble aggregates of tyrosine hydroxylase. J Biochem 139:625–635CrossRefPubMed
Zurück zum Zitat Wersinger C, Sidhu A (2002) Inflammation and Parkinson’s disease. Curr Drug Targets Inflamm Allergy 1:221–242CrossRefPubMed Wersinger C, Sidhu A (2002) Inflammation and Parkinson’s disease. Curr Drug Targets Inflamm Allergy 1:221–242CrossRefPubMed
Zurück zum Zitat Zhang NY, Tang Z, Liu CW (2008) α-Synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation: understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis. J Biol Chem 283:20288–20298CrossRefPubMed Zhang NY, Tang Z, Liu CW (2008) α-Synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation: understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis. J Biol Chem 283:20288–20298CrossRefPubMed
Metadaten
Titel
Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin–proteasome system in PC12D cells
verfasst von
Ichiro Kawahata
Hirofumi Tokuoka
Hasan Parvez
Hiroshi Ichinose
Publikationsdatum
01.12.2009
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 12/2009
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-009-0304-z

Weitere Artikel der Ausgabe 12/2009

Journal of Neural Transmission 12/2009 Zur Ausgabe

Basic Neurosciences, Genetics and Immunology - Short Communication

Upper gastrointestinal findings in Huntington’s disease: patients suffer but do not complain

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.